Skip to content
healthcare.dev

Menveo

NDC 58160-827, Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine, injection, solution, from GlaxoSmithKline Biologicals SA.

Product NDC
58160-827
Status
Listed
Labeler
GlaxoSmithKline Biologicals SA
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
VACCINE
Marketing category
BLA
Application
BLA125300
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/58160-827 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEISSERIA MENINGITIDIS GROUP A CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN10 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP C CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN5 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP W-135 CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN5 ug/.5mL
  • NEISSERIA MENINGITIDIS GROUP Y CAPSULAR OLIGOSACCHARIDE DIPHTHERIA CRM197 PROTEIN CONJUGATE ANTIGEN5 ug/.5mL

Pharmacologic classes

Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Actively Acquired Immunity [PE]; Inactivated Meningococcal Vaccine [EPC]; Inactivated Meningococcal Vaccine [EPC]; Inactivated Meningococcal Vaccine [EPC]; Inactivated Meningococcal Vaccine [EPC]; Meningococcal Vaccines [CS]; Meningococcal Vaccines [CS]; Meningococcal Vaccines [CS]; Meningococcal Vaccines [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]; Vaccines, Inactivated [CS]

Package NDCNDC-11Package
58160-827-305816008273010 VIAL in 1 CARTON (58160-827-30) / .5 mL in 1 VIAL (58160-827-03)

Linked data

RxNorm, label and prices

Use it

Look up 58160-827 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/58160-827 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 58160-827. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.